Michael Sinclair, Executive Chairman, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 3,500 shares at $7.01 ($25K) on 2017-01-17, disclosed to the SEC on 2017-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OPNT | SELL | 2022-06-08 | $209K | — | Filing → |
| OPNT | SELL | 2022-06-06 | $549K | — | Filing → |
| OPNT | SELL | 2021-08-25 | $3.6M | — | Filing → |